Abstract
BACKGROUND—Surgical resection is the recognised treatment of choice for patients with stage I or II non-small cell lung cancer (NSCLC). In the UK surgical resection rates have remained far lower (<10%) than those achieved in Europe and the USA (>20%), despite the recent introduction of fast access investigation units. It remains unclear therefore why UK surgical resection rates lag so far behind those of other countries. METHODS—A new quick access two stop investigation service was established at Papworth in November 1995 to investigate all patients presenting to any of three surrounding health districts with suspected lung cancer. Once staging was complete, all patients with confirmed lung cancer were reviewed by a multidisciplinary team which included an oncologist and a thoracic surgeon. Time from presentation to definitive treatment and surgical resection rates were reviewed. RESULTS—Two hundred and nine (76%) of a total of 275 consecutive patients investigated had confirmed lung cancer (28 small cell, 181non-small cell). Of the remainder, eight patients (2%) had metastatic disease, four (1%) had other thoracic malignancy (thymoma, mesothelioma), four patients (1%) had benign thoracic tumours, and 50 (18%) had other non-malignant diseases. Of the 181 patients with non-small cell primary lung cancer, 47 (25%) underwent successful surgical resection, of whom 59% had stage I and 21% stage II disease. The failed thoracotomy rate was 11%. Median time from presentation at the peripheral clinic to surgical resection was 5 weeks (range 1-13). CONCLUSION—Quick access investigation, high histological confirmation rates, routine CT scanning, and review of every patient with confirmed lung cancer by a thoracic surgeon led to a substantial increase in the successful surgical resection rate. These results support the growing concern that many patients with operable tumours are being denied the chance of curative surgery in our present system.
Full Text
The Full Text of this article is available as a PDF (82.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Billing J. S., Wells F. C. Delays in the diagnosis and surgical treatment of lung cancer. Thorax. 1996 Sep;51(9):903–906. doi: 10.1136/thx.51.9.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connolly C. K., Jones W. G., Thorogood J., Head C., Muers M. F. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer. 1990 Apr;61(4):579–583. doi: 10.1038/bjc.1990.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Damhuis R. A., Schütte P. R. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996 Jan;9(1):7–10. doi: 10.1183/09031936.96.09010007. [DOI] [PubMed] [Google Scholar]
- Humphrey E. W., Smart C. R., Winchester D. P., Steele G. D., Jr, Yarbro J. W., Chu K. C., Triolo H. H. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg. 1990 Dec;100(6):837–843. [PubMed] [Google Scholar]
- Steinbaum S. S., Uretzky I. D., McAdams H. P., Torrington K. G., Cohen A. J. Exploratory thoracotomy for nonresectable lung cancer. Chest. 1995 Apr;107(4):1058–1061. doi: 10.1378/chest.107.4.1058. [DOI] [PubMed] [Google Scholar]
- al-Kattan K., Sepsas E., Townsend E. R., Fountain S. W. Factors affecting long term survival following resection for lung cancer. Thorax. 1996 Dec;51(12):1266–1269. doi: 10.1136/thx.51.12.1266. [DOI] [PMC free article] [PubMed] [Google Scholar]